Log In
Print this Print this

Cerezyme, imiglucerase

  Manage Alerts
Collapse Summary General Information
Company Sanofi
DescriptionRecombinant glucocerebrosidase
Molecular Target Not available
Mechanism of ActionEnzyme replacement therapy
Therapeutic ModalityBiologic: Enzyme
Latest Stage of DevelopmentMarketed
Standard IndicationGaucher's disease
Indication DetailsImprove bone mineral density (BMD) in Type I Gaucher's disease patients; Treat Type I Gaucher's disease
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today